title: [Study of cytokines secreted by tumor-draining lymph node cells from lung cancer patients induced with different stimulators].
abstract: OBJECTIVE
  To investigate the influence of different stimulators on cytokines secretion of tumor-draining lymph node (TDLN) cells and study antitumor effects and mechanism of TDLN cells.
  
  
  METHODS
  IL-12 p70, IFN-gamma, TNF-alpha and NO which were secreted by TDLN cells induced by different stimulators (IL-2 group, IL-2+autologous tumor antigen group, IL-2+GM-CSF+IL-4+autologous tumor antigen group and IL-2+GM-CSF+IL-4+LPS group) were detected by ELISA and Griess after TDLN cells were stimulated for 7, 14 and 21 d.
  
  
  RESULTS
  The rate of CD83(+) cells of TDLN cells induced by IL-2+GM-CSF+IL-4+autologous tumor antigen and IL-2+GM-CSF+IL-4+LPS was significantly increased. The TDLN cells in the two groups secreted much more IL-12 p70, IFN-gamma and TNF-alpha than IL-2 group and IL-2+autologous tumor antigen group. The TDLN cells stimulated by IL-2+GM-CSF+IL-4+LPS secreted significantly more NO than the other three groups. TDLN cells in each group secreted IL-12 p70, IFN-gamma and NO at the highest level after TDLN cells were stimulated for 14 d.
  
  
  CONCLUSIONS
  Different stimulators can make TDLN cells produce different number of CD83(+) cells (DC), which gives TDLN cells different antitumor activity.
authors.affiliation: Research Center of the Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang 050011, China.
authors.forename: Qi-liang
authors.initials: QL
authors.lastname: Li
authors.forename: Bao-en
authors.initials: BE
authors.lastname: Shan
authors.forename: Chao
authors.initials: C
authors.lastname: Zhang
authors.forename: Ming
authors.initials: M
authors.lastname: He
authors.forename: Zheng-mao
authors.initials: ZM
authors.lastname: Zhang
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D015703:Antigens, CD / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism*; D004322:Drainage; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D007371:Interferon-gamma / Q000378:metabolism; D008175:Lung Neoplasms / Q000378:metabolism / Q000473:pathology*; D008198:Lymph Nodes / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D000097802:CD83 Antigen
chemical_list: D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D016207:Cytokines; D007136:Immunoglobulins; D007371:Interferon-gamma; D008562:Membrane Glycoproteins; D009569:Nitric Oxide; D014409:Tumor Necrosis Factor-alpha; D000097802:CD83 Antigen